Services

Evidence-led research (primary, secondary and synthesis) with the clinicians, payers and patients who shape treatment adoption. Delivered as full programmes or specialist fieldwork.

Qualitative market research

In-depth research with the healthcare stakeholders who prescribe, recommend, fund and use medicines.

Client problem

Clients need to understand treatment-decision drivers, adoption barriers and unmet needs before committing to positioning, endpoints or investment.

Decision supported

Clarify how stakeholders will respond before you lock strategy.

Methodologies

  • One-to-one interviews
  • Expert interviews
  • Focus groups
  • Online discussion boards
  • Advisory boards
  • Patient, payer and prescriber interviews
  • Treatment-pathway research

Deliverables

  • Unmet-needs analysis
  • Prescriber attitudes
  • Treatment-decision drivers
  • Adoption barriers
  • Patient journey insights
  • Message and concept testing
  • Treatment-pathway mapping
  • Clinical endpoint prioritisation

Quantitative market research

Structured research with larger samples to validate hypotheses and quantify market behaviour.

Client problem

Teams need demand estimates, preference structure and share scenarios grounded in stakeholder response, not desk assumptions alone.

Decision supported

Size opportunity and stress-test commercial assumptions with measured evidence.

Methodologies

  • Online physician, patient and payer surveys
  • Demand testing
  • Conjoint analysis
  • Discrete-choice exercises
  • Segmentation studies
  • Message prioritisation
  • Target product profile testing

Deliverables

  • Demand estimates
  • Prescribing intent
  • Market segmentation
  • Product preference
  • Adoption likelihood
  • Share scenarios
  • Price sensitivity
  • Commercial opportunity sizing

Healthcare fieldwork

Recruit the right participants and collect primary research data, standalone or as part of a full programme.

Client problem

High-quality healthcare research fails without specialist recruitment, screening, compliance and delivery discipline.

Decision supported

Secure trustworthy primary data from hard-to-reach respondents.

Methodologies

  • Specialist clinician, payer and patient recruitment
  • Eligibility screening and quotas
  • Interview and survey scheduling
  • Honoraria management
  • Translation and transcription
  • Consent and GDPR processes
  • Adverse-event reporting procedures
  • Quality control

Deliverables

  • Recordings and transcripts
  • Clean datasets
  • Recruitment logs and screening outcomes
  • Compliance documentation

Commercial opportunity assessment

Evidence-led judgement on whether a drug, asset, indication or market represents a credible commercial opportunity.

Client problem

Development and licensing teams must decide where to invest, how to position an asset and which assumptions need validation.

Decision supported

Choose where to play, and what to validate next.

Methodologies

  • Market attractiveness assessment
  • Indication and patient-segment prioritisation
  • Competitor and pipeline analysis
  • Prescriber adoption assessment
  • Treatment-positioning strategy
  • Revenue scenario development
  • Early market sizing
  • Partnering and licensing support

Deliverables

  • Prioritised opportunity map
  • Positioning options
  • Assumption register
  • Executive recommendations

Target product profile testing

Test how healthcare professionals and payers respond to different potential product profiles.

Client problem

Product profiles lock early. Clients need to know which characteristics drive clinical adoption and commercial value.

Decision supported

Define the profile most likely to win with physicians and payers.

Methodologies

  • Efficacy, safety and dosing trade-offs
  • Administration and treatment duration
  • Patient population and line of therapy
  • Clinical endpoints and monitoring
  • Combination use
  • Pricing and reimbursement conditions

Deliverables

  • Attribute importance
  • Adoption drivers and deal-breakers
  • Profile recommendations
  • Evidence implications

Pricing and market access

Clarify what evidence payers and reimbursement bodies would require, and where access barriers sit.

Client problem

Strong clinical stories fail commercially without a clear view of willingness to reimburse and evidence thresholds.

Decision supported

Align development and commercial plans with payer reality.

Methodologies

  • Willingness to reimburse
  • Evidence requirements
  • Pricing thresholds
  • Access restrictions and eligible populations
  • Budget-impact concerns
  • Health-economic value
  • HTA considerations
  • Market-specific access pathways

Deliverables

  • Access barriers and levers
  • Evidence priorities
  • Pricing corridors
  • Country-specific guidance

Competitive intelligence

Evaluate the commercial and clinical landscape around a product or therapeutic area.

Client problem

Clients need differentiation, market-entry risk and scenario planning grounded in current competitive dynamics.

Decision supported

Anticipate competitors and sharpen your position.

Methodologies

  • Competitor pipeline mapping
  • Product benchmarking
  • Clinical-trial comparisons
  • Mechanism-of-action analysis
  • Differentiation assessment
  • Market-entry risk reviews
  • Competitive positioning
  • Scenario planning

Deliverables

  • Competitive landscape maps
  • Differentiation narratives
  • Risk registers
  • Scenario packs for decision forums

Tell us about the decision you need to make.

Share the commercial or development question you are facing. We will come back with a clear view on approach, markets and timing.

Start a conversation